Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
300 GBX | +4.53% | +39.53% | +36.36% |
04-29 | FTSE 100 as investors look to Fed rate decision | AN |
04-29 | Transcript : Oxford Biomedica plc, Q4 2023 Earnings Call, Apr 29, 2024 |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
358M | - | |||||
104B | ||||||
97.47B | ||||||
22.25B | - | |||||
21.68B | - | |||||
18.2B |
- Stock Market
- Equities
- OXB Stock
- Charts Oxford Biomedica plc
- Sector Chart